Dr. Bozzette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 W Harbor Dr
Unit 1201
San Diego, CA 92101Phone+1 619-920-4543Fax+1 619-255-9500
Education & Training
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1982 - 1986
- University of Rochester School of Medicine and DentistryClass of 1982
Certifications & Licensure
- CA State Medical License 1984 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2000
Clinical Trials
- A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease
- The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS
- A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsEfficacy of infliximab, abatacept, and cenicriviroc for the treatment of adults hospitalized with COVID-19 pneumonia.Dan-Yu Lin, Jianqiao Wang, Kevin J Anstrom, Lisa M LaVange, Jun Wen
International Journal of Infectious Diseases. 2024-09-01 - Treatment of Adults Hospitalized With COVID-19 Pneumonia-Reply.William G Powderly, Lisa LaVange, Samuel A Bozzette
JAMA. 2023-12-05 - 31 citationsAbatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.Jane A O'Halloran, Emily R Ko, Kevin J Anstrom, Eyal Kedar, Matthew W McCarthy
JAMA. 2023-07-25
Press Mentions
- ResponseJuly 1st, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: